VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Immuno-oncology in MSI colorectal cancer

Thierry André • 20 Jan 2021
ASCO GI 2021
Colorectal Cancer Gastrointestinal Cancer
Immuno-Oncology

Thierry André, MD, Hospital Saint Antoine, Paris, France, outlines advances in the use of immunotherapy in patients with microsatellite instable (MSI) colorectal cancer, and future approaches in this field. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Genomic biomarkers in metastatic colorectal cancer

More from Thierry André

2:31
IDEA-FRANCE: ctDNA as a predictive value for adjuvant treatment duration
Thierry André • 29 Sep 2019
2:20
AVANT: bevacizumab + oxaliplatin-based chemo for colon cancer
Thierry André • 29 Sep 2019
2:11
Pembrolizumab vs. chemo in first-line mCRC
Thierry André • 18 Jan 2021
3:53
GARNET: dostarlimab, a PD-1 antibody in advanced solid tumors
Thierry André • 18 Jan 2021

Related Videos

1:44
EuropaColon survey of the unmet needs of metastatic colorectal cancer patients
Geoffrey Henning
3:24
COVID-19 & the management of cancer patients
Alberto F. Sobrero
1:20
A promising future for drug development in gastrointestinal cancer
Hani Babiker
2:31
Treatment landscape for HCC
Arndt Vogel
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals